RPO LLC’s SBC Medical Group SBC Stock Holding History

RPO LLC’s Portfolio SBC Stock Details SBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-426,804	Closed	-$4.46M	–	99
2023 Q1	$4.46M	Buy	+426,804	New	+$4.41M	1.36%	22

Other funds holding SBC

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return

OCM

Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

TCM

Tuttle Capital Management Riverside, Connecticut $148M AUM 64.07% 1-Year Est. Return

RPO LLC's SBC Position: Q2 2023 in Review

RPO LLC sold out of SBC Medical Group (SBC) in Q2 2023, closing a stake of 426,804 shares — an estimated $4.46M sold.

RPO LLC first reported a position in SBC in Q1 2023 and held it in 1 quarter. The position peaked at $4.46M in Q1 2023. 13 funds tracked by Wall St. Rank hold SBC as of Q2 2023.

RPO LLC reported no remaining SBC Medical Group position as of Q2 2023 after selling out during the quarter.
RPO LLC sold 426,804 SBC Medical Group shares in Q2 2023, an estimated $4.46M.
RPO LLC first reported a position in SBC Medical Group in Q1 2023 and held it in 1 quarter.
RPO LLC's SBC Medical Group position peaked at $4.46M in Q1 2023.
13 funds tracked by Wall St. Rank held SBC Medical Group as of Q2 2023.

Based on RPO LLC's 13F filing for Q2 2023, filed 9 Aug 2023.